Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: An observational study

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Ware, Carol B ^a   Nelson, Angelique M ^a   Liggitt, Denny ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MIFEPRISTONE; RECEPTOR SUBUNIT; CYTOKINE RECEPTOR; GLUCOCORTICOID RECEPTOR; HORMONE ANTAGONIST; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; LIF PROTEIN, MOUSE; LIFR PROTEIN, MOUSE; PROTEIN;

ADRENALECTOMY; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; FETUS; FETUS DEVELOPMENT; GESTATION PERIOD; GLIA CELL; HISTOLOGY; HORMONE RESPONSE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RECEPTOR AFFINITY; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; FETUS DISEASE; GENETICS; GERMFREE ANIMAL; GESTATIONAL AGE; GLIA; HOMEOSTASIS; HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; LETHAL GENE; MALE; METABOLIC BONE DISEASE; MOUSE MUTANT; MULTIPLE MALFORMATION SYNDROME; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; SKELETAL MUSCLE; SPINAL CORD;

ABNORMALITIES, MULTIPLE; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BONE DISEASES, METABOLIC; CORTICOSTERONE; FEMALE; FETAL DISEASES; FETUS; GENES, LETHAL; GESTATIONAL AGE; HOMEOSTASIS; HORMONE ANTAGONISTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIFEPRISTONE; MUSCLE, SKELETAL; NEUROGLIA; NEUROIMMUNOMODULATION; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, OSM-LIF; SPECIFIC PATHOGEN-FREE ORGANISMS; SPINAL CORD;

EID: 4344697201     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-43     Document Type: Article

References (77)

1. Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD: LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993, 260:1805-1808.
2. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI: Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995, 270:10915-10922.
3. Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, Scully S, Guo J, Elliott G, McNinch J, Shaklee CL, Freeman D, Manu F, Simonet WS, Boone T, Chang MS: Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci USA 1999, 96:11458-11463.
4. Elson GC, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, Suard I, de Coignac AB, Delneste Y, Bonnefoy JY, Gauchat JF, Gascan H: CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 2000, 3:867-872.
5. Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D: Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 1996, 271:32635-32643.
6. Ichihara M, Hara T, Kim H, Murate T, Miyajima A: Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood 1997, 90:165-173.
7. Turnley AM, Bartlett PF: Cytokines that signal through the leukemia inhibitory factor receptor-β complex in the nervous system. J Neurochem 2000, 74:889-899.
8. Wang Z, Ren SG, Melmed S: Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 1996, 137:2947-2953.
9. Akita S, Webster J, Ren S-G, Takino H, Said J, Zand O, Melmed S: Human and murine pituitary expression of leukemia inhibitory factor: novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest 1995, 95:1288-1298.
10. Carter DA: Leukaemia inhibitory factor expression in cultured rat anterior pituitary is regulated by glucocorticoids. J Neuroendocrinol 1995, 7:623-628.
11. Auernhammer CJ, Chesnokova V, Melmed S: Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology 1998, 139:2201-2208.
12. Kim DS, Melmed S: Stimulatory effect of leukemia inhibitory factor on ACTH secretion of dispersed rat pituitary cells. Endocr Res 1999, 25:11-19.
13. Akita S, Malkin J, Melmed S: Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology 1996, 137:3140-3143.
14. Ray DW, Ren SG, Melmed S: Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. J Clin Invest 1996, 97:1852-1859.
15. Bousquet C, Ray DW, Melmed S: A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy. J Biol Chem 1997, 272:10551-10557.
16. Chesnokova V, Auernhammer CJ, Melmed S: Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 1998, 139:2209-2216.
17. Bousquet C, Melmed S: Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling. J Biol Chem 1999, 274:10723-10730.
18. Li QL, Jansen E, Friedman TC: Regulation of prohormone convertase 1 (PC1) by gp130-related cytokines. Mol Cell Endocrinol 1999, 158:143-152.
19. Vutskits L, Bartanusz V, Schulz MF, Kiss JZ: Magnocellular vasopressinergic neurons in explant cultures are rescued from cell death by ciliary neurotrophic factor and leukemia inhibiting factor. Neuroscience 1998, 87:571-582.
20. Patterson PH, Chen LL: The induction of acetylcholine synthesis in primary cultures of dissociated rat sympathetic neurons, I. Effects of conditioned medium. Dev Bio 1977, 56:263-280.
21. Nawa H, Nakanishi S, Patterson PH: Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs. J Neurochem 1991, 56:2147-2150.
22. Murphy M, Dutton R, Koblar S, Cheema S, Bartlett P: Cytokines which signal through the LIF receptor and their actions in the nervous system. Prog Neurobiol 1997, 52:355-378.
23. Gadient RA, Patterson PH: Leukemia inhibitory factor, interleukin 6, and other cytokines using the gp130 transducing receptor: roles in inflammation and injury. Stem Cells 1999, 17:127-137.
24. Vogiagis D, Salamonsen LA: The role of leukaemia inhibitory factor in the establishment of pregnancy. J Endocrinol 1999, 160:181-190.
25. Auernhammer CJ, Melmed S: Leukemia-inhibitory factor - neuroimmune modulator of endocrine function. Endocrinol Rev 2000, 21:313-345.
26. Heymann D, Rousselle A-V: gp130 cytokine family and bone cells. Cytokine 2000, 12:1455-1468.
27. Touw IP, DeKoning JP, Ward AC, Hermans MHA: Signaling mechanisms of cytokine receptors and their perturbances in disease. Mol Cell Endocrinol 2000, 160:1-9.
28. Metcalf D, Gearing DP: Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 1989, 86:5948-5952.
29. Akita S, Readhead C, Stefaneanu L, Fine J, Tampanaru-Sarmesiu A, Kovacs K, Melmed S: Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function: a model for human pituitary Rathke's cysts. J Clin Invest 1997, 99:2464-2469.
30. Yano K, Readhead C, Nakashima M, Ren S-G, Melmed S: Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development. Mol Endocrinology 1998, 12:1708-1720.
31. Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar S, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995, 121:1283-1299.
32. Li M, Sendtner M, Smith A: Essential function of LIF receptor in motor neurons. Nature 1995, 378:724-727.
33. Soriano P, Montgomery C, Geske R, Bradley A: Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991, 64:693-702.
34. Hogan B, Beddington R, Costantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York 2 Edition 1994, 182.
35. Reichardt HM, Schütz G: Feedback control of glucocorticoid production is established during fetal development. Mol Med 1996, 2:735-744.
36. Charles River Laboratories [http://www.criver.com/products/surgery/adrenalectomy.html] 1997, 10:1.
37. Gendron-Maguire M, Mallo M, Zhang M, Gridley T: Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest. Cell 1993, 75:1317-1331.
38. Rijli FM, Mark M, Lakkaraju S, Dierich A, Dolle P, Chambon P: A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene. Cell 1993, 75:1333-1349.
39. Hill NCW, Selinger M, Ferguson J, MacKenzie IZ: Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester pregnancy. Hum Reprod 1991, 6:458-462.
40. DeChiara TM, Vejsada R, Poueymirou WT, Acheson A, Suri C, Conover JC, Friedman B, McClain J, Pan L, Stahl N, Ip NY, Kato A, Yancopoulos G: Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995, 83:313-322.
41. Liggins GC: The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev 1994, 6:141-150.
42. Hermus ARMM, Pieters GFFM, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW: Enhancement of ACTH response to human CRF by pretreatment with the antiglucocorticoid RU 486. Eur J Clin Pharmacol 1987, 31:609-611.
43. Agarwal MK: The anti-GC action of mifepristone. Pharmacol Ther 1996, 70:183-213.
44. Griffen JE, Ojeda SR: Textbook of Endocrine Physiology. Oxford University Press, New York 2000, 332.
45. Agarwal MK, Sekiya S, Lazar G: Antihormones: hormone-hormone anatagonism in glucocorticoid action in vivo. Elsevier, Amsterdam(Edited by: Agarwal MK). 1979, 51-73.
46. Agarwal MK, Sekiya S, Lazar SG: Search for anti-glucocorticoid activity in rat liver in vivo. Res Exp Med 1979, 176:181-192.
47. Agarwal MK, Hainque B, Moustaid N, Lazar G: Glucocorticoid antagonists. FEBS Lett 1987, 217:221-226.
48. Sakiz E: Survey on antiglucocorticoids. In Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action (Edited by: Furr, BJA, Wakeling, AE). Balliáre-Tindall, London 1987, 213-233.
49. Naylor PH, Rosen F: Antiglucocorticoids: differential antagonism of in vivo responses to dexamethasone. In Hormone Antagonists (Edited by: Agarwal MK). Walter de Gruyter, Berlin 1982, 365-380.
50. Landau RL, Lugibihl K: Inhibition of sodium retaining influence of aldosterone by progesterone. J Clin Endocrinol Metab 1958, 18:1237-1245.
51. Landau RL: Progesterone vs. aldosterone. In: Agarwal, M.K. (ed.) Antihormones (Edited by: Elsevier, Amsterdam). Agarwal MK 1979, 153-166.
52. Wambach G, Higgins JR: Antimineralocorticoid action of progesterone. In: Antihormones (Edited by: Agarwal MK). Elsevier, Amsterdam 1979, 167-180.
53. Wambach G, Helber A: Structure-activity relationship of antimineralocorticoid active steroids. In: Hormone Antagonists (Edited by: Walter de Gruyter, Berlin). Agarwal MK 1982, 293-306.
54. Bain SD, Jensen E, Celino DL, Bailey MC, Lantry MM, Edwards MW: High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse. J Bone Miner Res 1993, 8:219-229.
55. Cornish J, Callon K, King A, Edgar S, Reid IR: The effect of leukemia inhibitory factor on bone in vivo. Endocrinology 1993, 132:1359-1366.
56. Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC: Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest 1996, 97:431-437.
57. Cornish J, Callon KE, Edgar SG, Reid IR: Leukemia inhibitory factor is mitogenic to osteoblasts. Bone 1997, 21:243-247.
58. Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW: Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1995, 56(1-6 Spec. No):67-77.
59. Yang B, Zhou H-J, He Q-J, Fang R-Y: Termination of early pregnancy in the mouse, rat and hamster with DL111-1T and RU486. Contraception 2000, 62:211-216.
60. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross Jr J, Muller W, Chien KR: Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999, 97:189-198.
61. Yoshida K, Taga T, Saito M, Suematsu S, Kumanogoh A, Tanaka T, Fujiwara H, Hirata M, Yamagami T, Nakahata T, Hirabayashi T, Yoneda Y, Tanaka K, Wang WZ, Mori C, Shiota K, Yoshida N, Kishimoto T: Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 1995, 93:407-411.
62. Barnard W, Bower J, Brown MA, Murphy M, Austin L: Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle express LIF mRNA. J Neurol Sci 1994, 123:108-113.
63. Marques MJ, Neto HS: Ciliary neurotrophic factor stimulates in vivo myotube formation in mice. Neurosci Lett 1997, 234:43-46.
64. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL: Viral mediated expression in insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998, 95:15603-15607.
65. Chakravarthy MV, Abraha TW, Schwartz RJ, Fiorotto ML, Booth FW: Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway. J Biol Chem 2000, 275:35942-35952.
66. Austin L, Bower JJ, Bennett TM, Lynch GS, Kapsa R, White JD, Barnard W, Gregorevic P, Byrne E: Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse. Muscle Nerve 2000, 23:1700-1705.
67. Hers HG, DeWulf H, Stalmans W: The control of glycogen metabolism in liver. FEBS Lett 1970, 12:73-82.
68. Olefsky J, Kimmerling G: Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci 1976, 271:202-210.
69. Nishiyama K, Collodi P, Barnes D: Regulation of glial fibrillary acidic protein in serum free moue embryo (SFME) cells by leukemia inhibitory factor and related peptides. Neurosci Lett 1993, 163:114-116.
70. Koblar SA, Turnley SM, Classon B, Reid KL, Ware CB, Cheema SS, Murphy M, Bartlett PF: Neural precursor differentiation into astrocytes requires signalling through the LIF receptor. Proc Natl Acad Sci USA 1998, 95:3178-3181.
71. Nakashima K, Wiese S, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Yoshida K, Kishimoto T, Sendtner M, Taga T: Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci 1999, 19:5429-5434.
72. Nakashima K, Yanagisawa M, Arakawa H, Taga T: Astrocyte differentiation mediated by LIF in cooperation with BMP2. FEBS Lett 1999, 457:43-46.
73. Ochiai W, Yanagisawa M, Takizawa T, Nakashima K, Taga T: Astrocyte differentiation of fetal neuroepithelial cells involving cardiotrophin-1-induced activation of STAT3. Cytokine 2001, 14:264-271.
74. Maurel D, Sage D, Mekaouche M, Bosler O: Glucocorticoids up-regulate the expression of glial fibrillary acidic protein in the rat suprachiasmatic nucleus. Glia 2000, 29:212-221.
75. Heikinheimo O, Kekkonen R: Dose-response relationships of RU 486. Ann Med 1993, 25:71-76.
76. Morale MC, Gallo F, Tirolo C, Testa N, Caniglia S, Marletta N, Spina-Purrello V, Avola R, Caucci F, Tomasi P, Delitala G, Barden N, Marchetti B: Neuroendocrine-immune (NEI) circuitry from neuron-glial interactions to function: Focus on gender and HPA-HPG interactions on early programming of the NEI system. Imm Cell Biol 2001, 79:400-417.
77. Cole TJ, Blendy JA, Monaghan P, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995, 9:1608-1621.